Dr. Jami R. Erickson is a Senior Scientist in the molecular screening and characterization group at AbbVie in North Chicago. Her work focuses on high-throughput screening and innovative technique development, including the pioneering of flow-based CETSA techniques. Dr. Erickson earned her Ph.D. in Molecular, Cellular, Developmental Biology, and Genetics from the University of Minnesota, where she conducted her thesis research on regenerative medicine in Dr. Karen Echeverri’s laboratory. She later completed her postdoctoral studies at the Fred Hutchinson Cancer Research Center in Dr. Martin Prlic’s laboratory, utilizing scRNAseq to investigate the human immune response to cancer and viruses.